Semaglutide 2.4 mg efficacy and safety in people with obesity and knee osteoarthritis: Results: from the STEP 9 randomised clinical trial
Henning Bliddal, Harold Bays, Sébastien Czernichow, Joanna Uddén, Jøran Hjelmesæth, Thomas Morville, Anna Koroleva, Jesper Skov Neergaard, Sean Wharton, Alicja Wizert, L. E. Kristensen
Topics & Concepts
SemaglutideOsteoarthritisMedicineObesityPhysical therapyInternal medicineAlternative medicineEndocrinologyDiabetes mellitusPathologyType 2 diabetesLiraglutideDiabetes Treatment and ManagementPeptidase Inhibition and AnalysisInflammatory mediators and NSAID effects